These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12186474)

  • 41. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
    Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
    Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
    Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
    Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel therapies for meningiomas.
    Wen PY; Drappatz J
    Expert Rev Neurother; 2006 Oct; 6(10):1447-64. PubMed ID: 17078786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical management of meningioma in the era of precision medicine.
    Gupta S; Bi WL; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E3. PubMed ID: 29606052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progesterone receptors in tumor fragment spheroids of human meningiomas.
    Tonn JC; Ott MM; Paulus W; Meixensberger J; Roosen K
    Acta Neurochir Suppl; 1996; 65():105-7. PubMed ID: 8738509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids.
    Lam JT; Bauerschmitz GJ; Kanerva A; Barker SD; Straughn JM; Wang M; Barnes MN; Blackwell JL; Siegal GP; Alvarez RD; Curiel DT; Hemminki A
    Cancer Gene Ther; 2003 May; 10(5):377-87. PubMed ID: 12719707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells.
    Avci NG; Fan Y; Dragomir A; Akay YM; Gomez-Manzano C; Fueyo-Margareto J; Akay M
    IEEE Trans Nanobioscience; 2015 Dec; 14(8):946-51. PubMed ID: 26661633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip.
    Sasaki T; Hankins GR; Helm GA
    Neurosurgery; 2003 Apr; 52(4):892-8; discussion 898-9. PubMed ID: 12657186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene transfer into neural cells in vitro using adenoviral vectors.
    Southgate TD; Kingston PA; Castro MG
    Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.23. PubMed ID: 18428483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meningiomas and neurofibromatosis for the oncologist.
    Schrell UM; Fahlbusch R; Adams EF
    Curr Opin Oncol; 1994 May; 6(3):247-53. PubMed ID: 8080853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.
    Karsy M; Guan J; Cohen A; Colman H; Jensen RL
    Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic change of human cultured meningioma cells.
    Pallini R; Casalbore P; Mercanti D; Maggiano N; Larocca LM
    J Neurooncol; 2000 Aug; 49(1):9-17. PubMed ID: 11131990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights into meningioma: from genetics to trials.
    Vranic A; Peyre M; Kalamarides M
    Curr Opin Oncol; 2012 Nov; 24(6):660-5. PubMed ID: 22820412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetic features of meningiomas.
    Makashova ES; Lasunin NV; Galkin MV; Zolotova SV; Karandasheva KO; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(4):101-106. PubMed ID: 37650282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems.
    Chernyavska M; Schmid M; Freitag PC; Palacio-Castañeda V; Piruska A; Huck WTS; Plückthun A; Verdurmen WPR
    Sci Rep; 2019 Dec; 9(1):18568. PubMed ID: 31811202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies.
    Wickham TJ; Segal DM; Roelvink PW; Carrion ME; Lizonova A; Lee GM; Kovesdi I
    J Virol; 1996 Oct; 70(10):6831-8. PubMed ID: 8794324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer.
    Kim JW; Glasgow JN; Nakayama M; Ak F; Ugai H; Curiel DT
    PLoS One; 2013; 8(2):e55533. PubMed ID: 23383334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolving concepts in meningioma management in the era of genomics.
    Hsieh AL; Bi WL; Ramesh V; Brastianos PK; Plotkin SR
    Cancer; 2024 Aug; 130(15):2586-2600. PubMed ID: 38753473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways.
    Doukas J; Hoganson DK; Ong M; Ying W; Lacey DL; Baird A; Pierce GF; Sosnowski BA
    FASEB J; 1999 Aug; 13(11):1459-66. PubMed ID: 10428769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.
    Qin C; Huang M; Pan Y; Li Y; Long W; Liu Q
    Brain Tumor Pathol; 2021 Jul; 38(3):156-172. PubMed ID: 33903981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.